Primary Site >> Biliary tract Cancer

Gene >> RAB3D

Journal: World J Gastroenterol. 2007 Jun 7;13(21):2986-91.
Title: Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma.
Author: Chuensumran, Ubol|Wongkham, Sopit|Pairojkul, Chawalit|Chauin, Siri|Petmitr, Songsak
PMID: 17589952
Journal: N Engl J Med. 2010 Apr 8;362(14):1273-81.
Title: Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.
Author: Valle, Juan|Wasan, Harpreet|Palmer, Daniel H|Cunningham, David|Anthoney, Alan|Maraveyas, Anthony|Madhusudan, Srinivasan|Iveson, Tim|Hughes, Sharon|Pereira, Stephen P|Roughton, Michael|Bridgewater, John
PMID: 20375404
Journal: Lancet Oncol. 2010 Dec;11(12):1142-8.
Title: Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.
Author: Gruenberger, Birgit|Schueller, Johannes|Heubrandtner, Ute|Wrba, Fritz|Tamandl, Dietmar|Kaczirek, Klaus|Roka, Rudolf|Freimann-Pircher, Sandra|Gruenberger, Thomas
PMID: 21071270
Journal: JAMA. 2012 Jul 11;308(2):147-56.
Title: Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.
Author: Neoptolemos, John P|Moore, Malcolm J|Cox, Trevor F|Valle, Juan W|Palmer, Daniel H|McDonald, Alexander C|Carter, Ross|Tebbutt, Niall C|Dervenis, Christos|Smith, David|Glimelius, Bengt|Charnley, Richard M|Lacaine, Francois|Scarfe, Andrew G|Middleton, Mark R
PMID: 22782416
Journal: Lancet Oncol. 2014 Jul;15(8):819-28.
Title: Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.
Author: Malka, David|Cervera, Pascale|Foulon, Stephanie|Trarbach, Tanja|de la Fouchardiere, Christelle|Boucher, Eveline|Fartoux, Laetitia|Faivre, Sandrine|Blanc, Jean-Frederic|Viret, Frederic|Assenat, Eric|Seufferlein, Thomas|Herrmann, Thomas|Grenier, Julien|Hamm
PMID: 24852116
Journal: Trials. 2014 Aug 6;15:311.
Title: Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.
Author: Kloeckner, Roman|Ruckes, Christian|Kronfeld, Kai|Worns, Marcus Alexander|Weinmann, Arndt|Galle, Peter Robert|Lang, Hauke|Otto, Gerd|Eichhorn, Waltraud|Schreckenberger, Mathias|Dueber, Christoph|Pitton, Michael Bernhard
PMID: 25095718
Journal: Endoscopy. 2015 Aug;47(8):696-702.
Title: Prospective evaluation of the clinical utility of single-operator peroral cholangioscopy in patients with primary sclerosing cholangitis.
Author: Arnelo, Urban|von Seth, Erik|Bergquist, Annika
PMID: 25826274
Journal: BMC Cancer. 2015 Jul 31;15:564.
Title: Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial
Author: Stein, Alexander|Arnold, Dirk|Bridgewater, John|Goldstein, David|Jensen, Lars Henrik|Klumpen, Heinz-Josef|Lohse, Ansgar W|Nashan, Bjorn|Primrose, John|Schrum, Silke|Shannon, Jenny|Vettorazzi, Eik|Wege, Henning
PMID: 26228433
Journal: Expert Opin Investig Drugs. 2016 Dec;25(12):1423-1436.
Title: Novel investigational therapies for treating biliary tract carcinoma.
Author: Tampellini, M|La Salvia, A|Scagliotti, G V
PMID: 27771967
Journal: United European Gastroenterol J. 2017 Feb;5(1):104-110.
Title: Photodynamic therapy with polyhematoporphyrin for malignant biliary obstruction: A nationwide retrospective study of 150 consecutive applications.
Author: Dolak, Werner|Schwaighofer, Hubert|Hellmich, Brigitte|Stadler, Bernhard|Spaun, Georg|Plieschnegger, Wolfgang|Hebenstreit, Arnold|Weber-Eibel, Jutta|Siebert, Franz|Emmanuel, Klaus|Knoflach, Peter|Gschwantler, Michael|Vogel, Wolfgang|Trauner, Michael|Puspok
PMID: 28405328
Journal: Hepat Oncol. 2017 Apr;4(2):45-53.
Title: Hepatic intra-arterial and systemic chemotherapy followed by maintenance therapy for the treatment of cholangiocarcinoma.
Author: Fiorentini, Giammaria|Mambrini, Andrea|Sarti, Donatella|Cantore, Maurizio|Mulazzani, Luca|Mattioli, Gian Maria|Guadagni, Stefano
PMID: 30191053
Journal: World J Gastroenterol. 2017 Jun 14;23(22):3978-3998.
Title: Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.
Author: Sharma, Aarti|Sharma, Kiran Lata|Gupta, Annapurna|Yadav, Alka|Kumar, Ashok
PMID: 28652652
Journal: BMJ Open. 2017 Jun 10;7(6):e014961.
Title: Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours.
Author: Molenaar, Remco J|Coelen, Robert J S|Khurshed, Mohammed|Roos, Eva|Caan, Matthan W A|van Linde, Myra E|Kouwenhoven, Mathilde|Bramer, Jos A M|Bovee, Judith V M G|Mathot, Ron A|Klumpen, Heinz-Josef|van Laarhoven, Hanneke W M|van Noorden, Cornelis J F|Vandert
PMID: 28601826
Journal: Int J Clin Oncol. 2017 Apr;22(2):316-323.
Title: Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers.
Author: Nagayama, Satoshi|Hasegawa, Suguru|Hida, Koya|Kawada, Kenji|Hatano, Etsuro|Nakamura, Kojiro|Seo, Satoru|Taura, Kojiro|Yasuchika, Kentaro|Matsuo, Takashi|Zaima, Masazumi|Kanazawa, Akiyoshi|Terajima, Hiroaki|Tada, Masaharu|Adachi, Yukihito|Nishitai, Ryuta|M
PMID: 27752787
Journal: JAMA Oncol. 2018 Jan 1;4(1):40-47.
Title: Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial.
Author: Feng, Mary|Suresh, Krithika|Schipper, Matthew J|Bazzi, Latifa|Ben-Josef, Edgar|Matuszak, Martha M|Parikh, Neehar D|Welling, Theodore H|Normolle, Daniel|Ten Haken, Randall K|Lawrence, Theodore S
PMID: 28796864
Journal: Cancer Sci. 2018 Jan;109(1):215-224.
Title: Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine.
Author: Ikeda, Masafumi|Ioka, Tatsuya|Fukutomi, Akira|Morizane, Chigusa|Kasuga, Akiyoshi|Takahashi, Hideaki|Todaka, Akiko|Okusaka, Takuji|Creasy, Caretha L|Gorman, Shelby|Felitsky, Daniel J|Kobayashi, Mikiro|Zhang, Fanghong|Furuse, Junji
PMID: 29121415
Journal: J Clin Oncol. 2018 Jan 20;36(3):276-282.
Title: Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.
Author: Javle, Milind|Lowery, Maeve|Shroff, Rachna T|Weiss, Karl Heinz|Springfeld, Christoph|Borad, Mitesh J|Ramanathan, Ramesh K|Goyal, Lipika|Sadeghi, Saeed|Macarulla, Teresa|El-Khoueiry, Anthony|Kelley, Robin Kate|Borbath, Ivan|Choo, Su Pin|Oh, Do-Youn|Philip,
PMID: 29182496
Journal: BMC Cancer. 2018 Jan 11;18(1):72.
Title: Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study.
Author: Siebenhuner, Alexander R|Seifert, Heike|Bachmann, Helga|Seifert, Burkhardt|Winder, Thomas|Feilchenfeldt, Jonas|Breitenstein, Stefan|Clavien, Pierre-Alain|Stupp, Roger|Knuth, Alexander|Pestalozzi, Bernhard|Samaras, Panagiotis
PMID: 29325521
Journal: J Cancer. 2018 Apr 6;9(8):1476-1485.
Title: EGFR Target Therapy Combined with Gemox for Advanced Biliary Tract Cancers: a Meta-analysis based on RCTs.
Author: Cai, Wen|Yuan, Ying|Ge, Weiting|Fan, Yu|Liu, Xue|Wu, Dehao|Hu, Hanguang
PMID: 29721058
Journal: Cancer Chemother Pharmacol. 2018 Oct 27. pii: 10.1007/s00280-018-3708-3.
Title: Effect of a high-fat meal on the relative bioavailability of H3B-6527, a novel FGFR4 inhibitor, in healthy volunteers.
Author: Rioux, Nathalie|Kim, Amy|Nix, Darrell|Bowser, Todd|Warmuth, Markus|Smith, Peter G|Schindler, Joanne
PMID: 30368584